company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 15:24:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27112000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 15:24:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,3.3
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 15:24:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27112000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 15:24:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.24
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 15:24:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27112000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2008.0,FY,2008-01-01,2008-12-31,2011-02-28 15:24:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.3
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2009.0,FY,2009-01-01,2009-12-31,2011-02-28 15:24:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27404000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2009.0,FY,2009-01-01,2009-12-31,2011-02-28 15:24:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,5.28
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2009.0,FY,2009-01-01,2009-12-31,2011-02-28 15:24:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27404000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2009.0,FY,2009-01-01,2009-12-31,2011-02-28 15:24:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.2
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2009.0,FY,2009-01-01,2009-12-31,2011-02-28 15:24:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27404000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2009.0,FY,2009-01-01,2009-12-31,2011-02-28 15:24:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.28
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2009.0,Q3,2009-07-01,2009-09-30,2010-11-09 14:58:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27431000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2009.0,Q3,2009-07-01,2009-09-30,2010-11-09 14:58:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.4
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2009.0,Q3,2009-07-01,2009-09-30,2010-11-09 14:58:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27431000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2009.0,Q3,2009-07-01,2009-09-30,2010-11-09 14:58:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.38
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2009.0,Q3,2009-07-01,2009-09-30,2010-11-09 14:58:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27431000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2009.0,Q3,2009-07-01,2009-09-30,2010-11-09 14:58:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.4
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 12:56:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27370000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 12:56:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.39
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 12:56:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27370000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 12:56:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.37
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 12:56:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27370000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2009.0,Q2,2009-04-01,2009-06-30,2010-08-06 12:56:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.39
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1472884000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1472884000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,638523000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,638523000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,834361000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,481596000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,132003000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,613599000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,220762000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,49273000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1025000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-50298000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,170464000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,18921000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,151543000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,151543000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,914000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,150629000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27665000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.44
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28151000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.41
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27700000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q4,2010-10-01,2010-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.44
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,FY,2010-01-01,2010-12-31,2013-03-18 16:27:34+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1927118000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,FY,2010-01-01,2010-12-31,2013-03-18 16:27:34+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1927118000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,FY,2010-01-01,2010-12-31,2013-03-18 16:27:34+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,835630000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,FY,2010-01-01,2010-12-31,2013-03-18 16:27:34+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,835630000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,FY,2010-01-01,2010-12-31,2013-03-18 16:27:34+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1091488000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,FY,2010-01-01,2010-12-31,2013-03-18 16:27:34+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,635213000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,FY,2010-01-01,2010-12-31,2013-03-18 16:27:34+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,172266000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,FY,2010-01-01,2010-12-31,2013-03-18 16:27:34+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,807479000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,FY,2010-01-01,2010-12-31,2013-03-18 16:27:34+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,284009000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,FY,2010-01-01,2010-12-31,2013-03-18 16:27:34+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,63717000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,FY,2010-01-01,2010-12-31,2013-03-18 16:27:34+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-9000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,FY,2010-01-01,2010-12-31,2013-03-18 16:27:34+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-63726000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,FY,2010-01-01,2010-12-31,2013-03-18 16:27:34+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,220283000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,FY,2010-01-01,2010-12-31,2013-03-18 16:27:34+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,33348000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,FY,2010-01-01,2010-12-31,2013-03-18 16:27:34+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,186935000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,FY,2010-01-01,2010-12-31,2013-03-18 16:27:34+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,186935000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,FY,2010-01-01,2010-12-31,2013-03-18 16:27:34+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,1445000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,FY,2010-01-01,2010-12-31,2013-03-18 16:27:34+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,185490000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,FY,2010-01-01,2010-12-31,2013-03-18 16:27:34+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27665000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,FY,2010-01-01,2010-12-31,2013-03-18 16:27:34+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,6.7
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,FY,2010-01-01,2010-12-31,2013-03-18 16:27:34+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28151000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,FY,2010-01-01,2010-12-31,2013-03-18 16:27:34+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,6.59
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,FY,2010-01-01,2010-12-31,2013-03-18 16:27:34+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27700000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,FY,2010-01-01,2010-12-31,2013-03-18 16:27:34+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,6.7
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q3,2010-07-01,2010-09-30,2010-11-09 14:58:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27697000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q3,2010-07-01,2010-09-30,2010-11-09 14:58:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.62
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q3,2010-07-01,2010-09-30,2010-11-09 14:58:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27697000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q3,2010-07-01,2010-09-30,2010-11-09 14:58:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.59
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q3,2010-07-01,2010-09-30,2010-11-09 14:58:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27697000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q3,2010-07-01,2010-09-30,2010-11-09 14:58:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.62
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,454234000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,454234000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,197107000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,197107000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,257127000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,153617000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,40263000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q3YTD,2010-01-01,2010-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,193880000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,63247000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,14444000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1016000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q3YTD,2010-01-01,2010-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-13428000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,49819000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,14427000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,35392000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,35392000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q3YTD,2010-01-01,2010-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,531000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q3YTD,2010-01-01,2010-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,34861000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q3YTD,2010-01-01,2010-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27697000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q3YTD,2010-01-01,2010-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.26
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q3YTD,2010-01-01,2010-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27697000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q3YTD,2010-01-01,2010-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.18
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q3YTD,2010-01-01,2010-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27697000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q3YTD,2010-01-01,2010-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.26
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q2,2010-04-01,2010-06-30,2010-08-06 12:56:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27606000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q2,2010-04-01,2010-06-30,2010-08-06 12:56:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.37
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q2,2010-04-01,2010-06-30,2010-08-06 12:56:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27606000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q2,2010-04-01,2010-06-30,2010-08-06 12:56:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.35
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q2,2010-04-01,2010-06-30,2010-08-06 12:56:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27606000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q2,2010-04-01,2010-06-30,2010-08-06 12:56:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.37
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,454234000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,454234000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,197107000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,197107000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,257127000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,153617000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,40263000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q2YTD,2010-01-01,2010-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,193880000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,63247000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,14444000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1016000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q2YTD,2010-01-01,2010-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-13428000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,49819000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,14427000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,35392000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,35392000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q2YTD,2010-01-01,2010-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,531000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q2YTD,2010-01-01,2010-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,34861000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q2YTD,2010-01-01,2010-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27606000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q2YTD,2010-01-01,2010-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.64
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q2YTD,2010-01-01,2010-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,27606000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q2YTD,2010-01-01,2010-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.59
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q2YTD,2010-01-01,2010-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27606000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q2YTD,2010-01-01,2010-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.64
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,454234000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,454234000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,197107000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,197107000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,257127000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,153617000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,40263000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,193880000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,63247000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,14444000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1016000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-13428000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,49819000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,14427000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,35392000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,35392000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,531000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,34861000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27545000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.27
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28072000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.24
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,27400000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2010.0,Q1,2010-01-01,2010-03-31,2011-05-06 14:45:36+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.27
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,FY,2011-01-01,2011-12-31,2014-03-17 18:31:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2073529000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,FY,2011-01-01,2011-12-31,2014-03-17 18:31:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2073529000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,FY,2011-01-01,2011-12-31,2014-03-17 18:31:45+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,894700000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,FY,2011-01-01,2011-12-31,2014-03-17 18:31:45+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,894700000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,FY,2011-01-01,2011-12-31,2014-03-17 18:31:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1178829000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,FY,2011-01-01,2011-12-31,2014-03-17 18:31:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,695984000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,FY,2011-01-01,2011-12-31,2014-03-17 18:31:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,177604000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,FY,2011-01-01,2011-12-31,2014-03-17 18:31:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,873588000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,FY,2011-01-01,2011-12-31,2014-03-17 18:31:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,305241000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,FY,2011-01-01,2011-12-31,2014-03-17 18:31:45+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,53135000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,FY,2011-01-01,2011-12-31,2014-03-17 18:31:45+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-6259000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,FY,2011-01-01,2011-12-31,2014-03-17 18:31:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-59394000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,FY,2011-01-01,2011-12-31,2014-03-17 18:31:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,245847000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,FY,2011-01-01,2011-12-31,2014-03-17 18:31:45+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,67034000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,FY,2011-01-01,2011-12-31,2014-03-17 18:31:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,178813000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,FY,2011-01-01,2011-12-31,2014-03-17 18:31:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,178813000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,FY,2011-01-01,2011-12-31,2014-03-17 18:31:45+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-200000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,FY,2011-01-01,2011-12-31,2014-03-17 18:31:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,179013000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,FY,2011-01-01,2011-12-31,2014-03-17 18:31:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28031000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,FY,2011-01-01,2011-12-31,2014-03-17 18:31:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,6.39
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,FY,2011-01-01,2011-12-31,2014-03-17 18:31:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28468000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,FY,2011-01-01,2011-12-31,2014-03-17 18:31:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,6.29
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,FY,2011-01-01,2011-12-31,2014-03-17 18:31:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28000000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,FY,2011-01-01,2011-12-31,2014-03-17 18:31:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,6.39
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,550238000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,550238000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,238332000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,238332000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,311906000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,174614000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,41277000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,215891000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,96015000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11987000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-34000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-12021000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,83994000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,24003000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,59991000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,59991000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-38000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,60029000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28031000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.15
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28468000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.11
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28000000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.15
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,516514000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,516514000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,220338000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,220338000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,296176000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,176867000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,45387000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,222254000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,73922000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,12341000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-5808000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-18149000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,55773000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,9911000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,45862000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,45862000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-35000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,45897000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28072000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.63
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28456000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.61
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28200000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3,2011-07-01,2011-09-30,2011-11-03 13:35:18+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.63
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1523291000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1523291000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,656368000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,656368000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,866923000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,521370000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,136327000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,657697000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,209226000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,41148000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-6225000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-47373000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,161853000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,43031000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,118822000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,118822000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-162000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,118984000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28072000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.24
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28456000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.18
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28200000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3YTD,2011-01-01,2011-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.24
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2996175000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2996175000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1294891000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1294891000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1701284000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1002966000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,268330000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1271296000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,429988000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,90421000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-7250000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-97671000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,332317000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,61952000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,270365000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,270365000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,752000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,269613000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28072000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,6.68
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28456000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,6.59
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28200000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q3TTM,2010-10-01,2011-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,6.68
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,521656000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,521656000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,228520000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,228520000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,293136000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,176740000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,48210000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,224950000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,68186000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,12041000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1674000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10367000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,57819000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,17797000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,40022000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,40022000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-26000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,40048000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28014000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.43
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28495000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.41
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28000000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2,2011-04-01,2011-06-30,2011-08-03 17:46:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.43
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1006777000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1006777000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,436030000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,436030000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,570747000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,344503000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,90940000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,435443000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,135304000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,28807000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-417000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-29224000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,106080000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,33120000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,72960000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,72960000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-127000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,73087000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28014000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.61
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28495000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.57
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28000000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2YTD,2011-01-01,2011-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.61
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2479661000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2479661000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1074553000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1074553000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1405108000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,826099000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,222943000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1049042000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,356066000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,78080000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1442000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-79522000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,276544000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,52041000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,224503000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,224503000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,787000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,223716000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28014000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,6.67
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28495000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,6.57
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28000000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q2TTM,2010-07-01,2011-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,6.67
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,485121000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,485121000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,207510000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,207510000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,277611000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,167763000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,42730000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,210493000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,67118000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,16766000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2091000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-18857000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,48261000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,15323000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,32938000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,32938000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-101000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,33039000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27904000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.18
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28389000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.16
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28000000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1,2011-01-01,2011-03-31,2011-05-06 14:45:36+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.18
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1958005000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1958005000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,846033000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,846033000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1111972000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,649359000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,174733000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1TTM,2010-04-01,2011-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,824092000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,287880000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,66039000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3116000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1TTM,2010-04-01,2011-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-69155000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,218725000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,34244000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,184481000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,184481000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1TTM,2010-04-01,2011-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,813000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1TTM,2010-04-01,2011-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,183668000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1TTM,2010-04-01,2011-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,27904000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1TTM,2010-04-01,2011-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,6.61
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1TTM,2010-04-01,2011-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28389000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1TTM,2010-04-01,2011-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,6.51
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1TTM,2010-04-01,2011-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28000000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2011.0,Q1TTM,2010-04-01,2011-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,6.61
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,573839000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,573839000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,258673000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,258673000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,315166000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,187955000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,54941000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,242896000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,72270000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,13614000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5659000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7955000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,64315000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,20649000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,43666000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,43666000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-79000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,43745000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28290000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.54
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28642000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.52
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28300000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.54
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,FY,2012-01-01,2012-12-31,2015-03-02 15:01:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2069235000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,FY,2012-01-01,2012-12-31,2015-03-02 15:01:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2069235000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,FY,2012-01-01,2012-12-31,2015-03-02 15:01:26+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,914077000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,FY,2012-01-01,2012-12-31,2015-03-02 15:01:26+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,914077000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,FY,2012-01-01,2012-12-31,2015-03-02 15:01:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1155158000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,FY,2012-01-01,2012-12-31,2015-03-02 15:01:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,681778000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,FY,2012-01-01,2012-12-31,2015-03-02 15:01:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,209204000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,FY,2012-01-01,2012-12-31,2015-03-02 15:01:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,890982000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,FY,2012-01-01,2012-12-31,2015-03-02 15:01:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,264176000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,FY,2012-01-01,2012-12-31,2015-03-02 15:01:26+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,51112000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,FY,2012-01-01,2012-12-31,2015-03-02 15:01:26+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,16843000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,FY,2012-01-01,2012-12-31,2015-03-02 15:01:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-34269000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,FY,2012-01-01,2012-12-31,2015-03-02 15:01:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,229907000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,FY,2012-01-01,2012-12-31,2015-03-02 15:01:26+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,64361000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,FY,2012-01-01,2012-12-31,2015-03-02 15:01:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,165546000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,FY,2012-01-01,2012-12-31,2015-03-02 15:01:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,165546000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,FY,2012-01-01,2012-12-31,2015-03-02 15:01:26+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,69000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,FY,2012-01-01,2012-12-31,2015-03-02 15:01:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,165477000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,FY,2012-01-01,2012-12-31,2015-03-02 15:01:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28290000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,FY,2012-01-01,2012-12-31,2015-03-02 15:01:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,5.85
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,FY,2012-01-01,2012-12-31,2015-03-02 15:01:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28642000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,FY,2012-01-01,2012-12-31,2015-03-02 15:01:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.78
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,FY,2012-01-01,2012-12-31,2015-03-02 15:01:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28300000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,FY,2012-01-01,2012-12-31,2015-03-02 15:01:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.85
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,498697000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,498697000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,225187000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,225187000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,273510000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,160274000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,49004000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,209278000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,64232000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11901000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1063000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10838000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,53394000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,11023000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,42371000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,42371000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-13000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,42384000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28312000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.5
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28645000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.48
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28300000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3,2012-07-01,2012-09-30,2012-11-08 16:08:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.5
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1495396000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1495396000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,655404000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,655404000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,839992000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,493823000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,154263000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,648086000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,191906000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,37498000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,11184000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-26314000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,165592000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,43712000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,121880000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,121880000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,148000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,121732000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28312000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.31
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28645000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.26
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28300000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3YTD,2012-01-01,2012-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.31
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2045634000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2045634000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,893736000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,893736000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1151898000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,668437000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,195540000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,863977000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,287921000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,49485000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,11150000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-38335000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,249586000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,67715000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,181871000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,181871000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,110000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,181761000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28312000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,6.46
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28645000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,6.37
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28300000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q3TTM,2011-10-01,2012-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,6.46
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,510422000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,510422000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,222522000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,222522000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,287900000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,162256000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,52336000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,214592000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,73308000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,12401000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5112000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7289000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,66019000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,17454000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,48565000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,48565000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,222000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,48343000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28250000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.71
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28610000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.69
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28300000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2,2012-04-01,2012-06-30,2012-08-09 12:37:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.71
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,996699000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,996699000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,430217000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,430217000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,566482000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,333549000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,105259000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,438808000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,127674000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,25597000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,10121000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-15476000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,112198000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,32689000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,79509000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,79509000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,161000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,79348000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28250000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.81
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28610000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.78
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28300000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2YTD,2012-01-01,2012-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.81
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2063451000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2063451000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,888887000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,888887000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1174564000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,685030000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,191923000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,876953000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,297611000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,49925000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4279000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-45646000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,251965000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,66603000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,185362000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,185362000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,88000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,185274000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28250000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,6.59
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28610000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,6.5
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28300000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q2TTM,2011-07-01,2012-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,6.59
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,486277000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,486277000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,207695000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,207695000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,278582000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,171293000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,52923000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,224216000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,54366000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,13196000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5009000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8187000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,46179000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,15235000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,30944000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,30944000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-61000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,31005000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28201000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.1
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28553000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.09
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28200000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 14:41:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.1
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2074685000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2074685000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,894885000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,894885000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1179800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,699514000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,187797000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,887311000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,292489000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,49565000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,841000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-48724000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,243765000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,66946000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,176819000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,176819000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-160000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,176979000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28201000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,6.31
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28553000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,6.22
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28200000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2012.0,Q1TTM,2011-04-01,2012-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,6.31
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,FY,2013-01-01,2013-12-31,2014-03-17 18:31:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2132694000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,FY,2013-01-01,2013-12-31,2014-03-17 18:31:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2132694000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,FY,2013-01-01,2013-12-31,2014-03-17 18:31:45+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,954216000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,FY,2013-01-01,2013-12-31,2014-03-17 18:31:45+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,954216000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,FY,2013-01-01,2013-12-31,2014-03-17 18:31:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1178478000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,FY,2013-01-01,2013-12-31,2014-03-17 18:31:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,798070000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,FY,2013-01-01,2013-12-31,2014-03-17 18:31:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,210952000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,FY,2013-01-01,2013-12-31,2014-03-17 18:31:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1009022000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,FY,2013-01-01,2013-12-31,2014-03-17 18:31:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,169456000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,FY,2013-01-01,2013-12-31,2014-03-17 18:31:45+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,61271000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,FY,2013-01-01,2013-12-31,2014-03-17 18:31:45+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4200000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,FY,2013-01-01,2013-12-31,2014-03-17 18:31:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-57071000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,FY,2013-01-01,2013-12-31,2014-03-17 18:31:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,112385000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,FY,2013-01-01,2013-12-31,2014-03-17 18:31:45+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,34574000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,FY,2013-01-01,2013-12-31,2014-03-17 18:31:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,77811000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,FY,2013-01-01,2013-12-31,2014-03-17 18:31:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,77811000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,FY,2013-01-01,2013-12-31,2014-03-17 18:31:45+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,21000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,FY,2013-01-01,2013-12-31,2014-03-17 18:31:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,77790000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,FY,2013-01-01,2013-12-31,2014-03-17 18:31:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28586000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,FY,2013-01-01,2013-12-31,2014-03-17 18:31:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,2.72
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,FY,2013-01-01,2013-12-31,2014-03-17 18:31:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28906000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,FY,2013-01-01,2013-12-31,2014-03-17 18:31:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.69
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,FY,2013-01-01,2013-12-31,2014-03-17 18:31:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28600000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,FY,2013-01-01,2013-12-31,2014-03-17 18:31:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.72
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,602635000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,602635000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,279886000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,279886000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,322749000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,214584000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,54250000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,268834000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,53915000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7019000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-788000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7807000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,46108000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,15320000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,30788000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,30788000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,30788000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28586000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.08
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28906000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.06
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28600000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.08
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1530059000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1530059000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,674330000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,674330000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,855729000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,583486000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,156702000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3YTD,2013-01-01,2013-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,740188000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,115541000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,54252000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4988000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3YTD,2013-01-01,2013-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-49264000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,66277000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,19254000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,47023000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,47023000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3YTD,2013-01-01,2013-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,21000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3YTD,2013-01-01,2013-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,47002000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3YTD,2013-01-01,2013-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28603000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3YTD,2013-01-01,2013-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.64
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3YTD,2013-01-01,2013-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28603000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3YTD,2013-01-01,2013-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.63
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3YTD,2013-01-01,2013-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28400000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3YTD,2013-01-01,2013-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.64
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2103898000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2103898000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,933003000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,933003000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1170895000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,771441000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,211643000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,983084000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,187811000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,67866000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,10647000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-57219000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,130592000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,39903000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,90689000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,90689000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-58000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,90747000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28603000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.18
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28603000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.15
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28400000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3TTM,2012-10-01,2013-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.18
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,505066000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,505066000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,220850000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,220850000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,284216000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,202238000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,52920000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,255158000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,29058000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,31611000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2663000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-34274000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5216000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,1883000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7099000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7099000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7099000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28603000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.25
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28603000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.25
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28400000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q3,2013-07-01,2013-09-30,2014-11-07 13:58:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.25
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1024993000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1024993000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,453480000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,453480000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,571513000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,381248000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,103782000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2YTD,2013-01-01,2013-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,485030000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,86483000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,22641000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,7651000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2YTD,2013-01-01,2013-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-14990000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,71493000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,17371000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,54122000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,54122000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2YTD,2013-01-01,2013-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,21000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2YTD,2013-01-01,2013-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,54101000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2YTD,2013-01-01,2013-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28538000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2YTD,2013-01-01,2013-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.89
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2YTD,2013-01-01,2013-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28868000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2YTD,2013-01-01,2013-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.88
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2YTD,2013-01-01,2013-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28600000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2YTD,2013-01-01,2013-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.89
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2097529000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2097529000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,937340000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,937340000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1160189000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,729477000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,207727000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,937204000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,222985000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,48156000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,14373000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-33783000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,189202000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,49043000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,140159000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,140159000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,-71000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,140230000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28538000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.93
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28868000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.88
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28600000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2TTM,2012-07-01,2013-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.93
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,525321000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,525321000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,225220000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,225220000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,300101000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,195331000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,51841000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,247172000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,52929000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11664000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,7779000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3885000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,49044000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,14442000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,34602000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,34602000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,34602000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28538000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.21
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28868000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.2
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28600000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q2,2013-04-01,2013-06-30,2014-08-06 17:17:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.21
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,499672000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,499672000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,228260000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,228260000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,271412000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,185917000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,51941000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,237858000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,33554000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,10977000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-128000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-11105000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,22449000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2929000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,19520000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,19520000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,21000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,19499000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28494000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.68
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28817000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.68
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28700000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1,2013-01-01,2013-03-31,2013-05-10 16:51:39+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.68
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2082630000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2082630000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,934642000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,934642000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1147988000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,696402000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,208222000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,904624000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,243364000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,48893000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,11706000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-37187000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,206177000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,52055000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,154122000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,154122000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,netincometocommon,netincometononcontrollinginterest,Net Income / (Loss) Attributable to Noncontrolling Interest,-,debit,usd,151000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,153971000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28494000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,5.43
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,28817000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,5.37
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28700000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2013.0,Q1TTM,2012-04-01,2013-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,5.43
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 20:11:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2175000000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 20:11:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2175000000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 20:11:41+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,996527000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 20:11:41+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,996527000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 20:11:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1178517000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 20:11:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,808200000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 20:11:41+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,220333000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 20:11:41+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 20:11:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1028533000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 20:11:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,149984000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 20:11:41+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,22131000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 20:11:41+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3695000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 20:11:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-18436000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 20:11:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,131600000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 20:11:41+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,42700000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 20:11:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,88900000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 20:11:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,88800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 20:11:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,88800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 20:11:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28876000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 20:11:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,3.08
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 20:11:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29133000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 20:11:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.05
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 20:11:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,FY,2014-01-01,2014-12-31,2017-02-28 20:11:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.08
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,598180000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,598180000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,280814000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,280814000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,317410000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,207537000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,59287000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,266824000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,50586000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5000000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,151000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4849000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,45789000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6697000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,39092000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,38992000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,38992000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28876000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.35
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29133000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.34
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.35
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 18:15:23+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,530644000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 18:15:23+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,530644000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 18:15:23+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,242068000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 18:15:23+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,242068000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 18:15:23+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,288576000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 18:15:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,202550000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 18:15:23+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,52786000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 18:15:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,255336000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 18:15:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,33240000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 18:15:23+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,7710000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 18:15:23+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-3054000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 18:15:23+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10764000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 18:15:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,22476000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 18:15:23+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,10967000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 18:15:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,11509000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 18:15:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,11509000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 18:15:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,11509000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 18:15:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28884000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 18:15:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.4
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 18:15:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29141000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 18:15:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.39
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 18:15:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3,2014-07-01,2014-09-30,2015-11-04 18:15:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.4
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1576820000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1576820000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,715713000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,715713000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,861107000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,600663000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,161046000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3YTD,2014-01-01,2014-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,761709000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,99398000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,17131000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3544000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3YTD,2014-01-01,2014-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-13587000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,85811000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,36003000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,49808000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3YTD,2014-01-01,2014-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,49808000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3YTD,2014-01-01,2014-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,49808000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3YTD,2014-01-01,2014-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28884000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3YTD,2014-01-01,2014-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.73
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3YTD,2014-01-01,2014-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29141000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3YTD,2014-01-01,2014-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.71
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3YTD,2014-01-01,2014-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3YTD,2014-01-01,2014-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.73
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2179455000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2179455000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,995599000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,995599000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1183856000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,815247000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,215296000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3TTM,2013-10-01,2014-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1030543000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,153313000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,24150000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2756000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3TTM,2013-10-01,2014-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-21394000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,131919000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,51323000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,80596000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3TTM,2013-10-01,2014-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,80596000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3TTM,2013-10-01,2014-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,80596000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3TTM,2013-10-01,2014-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28884000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3TTM,2013-10-01,2014-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.81
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3TTM,2013-10-01,2014-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29141000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3TTM,2013-10-01,2014-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.77
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3TTM,2013-10-01,2014-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q3TTM,2013-10-01,2014-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.81
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1046176000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1046176000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,473645000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,473645000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,572531000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,398113000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,108260000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2YTD,2014-01-01,2014-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,506373000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,66158000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9421000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,6598000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2YTD,2014-01-01,2014-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2823000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,63335000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,25036000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,38299000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2YTD,2014-01-01,2014-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,38299000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2YTD,2014-01-01,2014-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,38299000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2YTD,2014-01-01,2014-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28826000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2YTD,2014-01-01,2014-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.33
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2YTD,2014-01-01,2014-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29092000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2YTD,2014-01-01,2014-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.32
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2YTD,2014-01-01,2014-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2YTD,2014-01-01,2014-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.33
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2153877000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2153877000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,974381000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,974381000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1179496000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,814935000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,215430000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2TTM,2013-07-01,2014-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1030365000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,149131000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,48051000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3147000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2TTM,2013-07-01,2014-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-44904000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,104227000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,42239000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,61988000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2TTM,2013-07-01,2014-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,61988000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2TTM,2013-07-01,2014-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,61988000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2TTM,2013-07-01,2014-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28826000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2TTM,2013-07-01,2014-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.16
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2TTM,2013-07-01,2014-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29092000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2TTM,2013-07-01,2014-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.13
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2TTM,2013-07-01,2014-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2TTM,2013-07-01,2014-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.16
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:15:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,536832000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:15:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,536832000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:15:54+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,239590000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:15:54+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,239590000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:15:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,297242000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:15:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,195838000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:15:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,55717000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:15:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,251555000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:15:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,45687000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:15:54+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5564000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:15:54+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,8674000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:15:54+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,3110000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:15:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,48797000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:15:54+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,17166000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:15:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,31631000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:15:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,31631000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:15:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,31631000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:15:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28826000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:15:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,1.1
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:15:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29092000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:15:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.09
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:15:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,28800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 13:15:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.1
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2142366000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2142366000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,960011000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,960011000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1182355000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,814428000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,211554000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1025982000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,156373000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,54151000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2252000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-51899000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,104474000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,39515000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,64959000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,64959000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,64959000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28791000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.27
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29059000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.24
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29000000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1TTM,2013-04-01,2014-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.27
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,509344000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,509344000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,234055000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,234055000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,275289000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,202275000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,52543000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,254818000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,20471000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3857000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2076000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5933000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,14538000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,7870000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,6668000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,6668000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,6668000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,28791000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.23
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29059000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.23
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29000000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2014.0,Q1,2014-01-01,2014-03-31,2015-05-06 16:33:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.23
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,FY,2015-01-01,2015-12-31,2018-04-13 17:50:43+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2019400000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,FY,2015-01-01,2015-12-31,2018-04-13 17:50:43+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2019400000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,FY,2015-01-01,2015-12-31,2018-04-13 17:50:43+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,897771000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,FY,2015-01-01,2015-12-31,2018-04-13 17:50:43+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,897771000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,FY,2015-01-01,2015-12-31,2018-04-13 17:50:43+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1121670000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,FY,2015-01-01,2015-12-31,2018-04-13 17:50:43+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,761990000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,FY,2015-01-01,2015-12-31,2018-04-13 17:50:43+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,192972000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,FY,2015-01-01,2015-12-31,2018-04-13 17:50:43+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,FY,2015-01-01,2015-12-31,2018-04-13 17:50:43+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,954962000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,FY,2015-01-01,2015-12-31,2018-04-13 17:50:43+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,166708000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,FY,2015-01-01,2015-12-31,2018-04-13 17:50:43+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,21692000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,FY,2015-01-01,2015-12-31,2018-04-13 17:50:43+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,851000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,FY,2015-01-01,2015-12-31,2018-04-13 17:50:43+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-20841000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,FY,2015-01-01,2015-12-31,2018-04-13 17:50:43+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,145800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,FY,2015-01-01,2015-12-31,2018-04-13 17:50:43+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,36600000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,FY,2015-01-01,2015-12-31,2018-04-13 17:50:43+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,109200000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,FY,2015-01-01,2015-12-31,2018-04-13 17:50:43+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,109200000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,FY,2015-01-01,2015-12-31,2018-04-13 17:50:43+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,109200000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,FY,2015-01-01,2015-12-31,2018-04-13 17:50:43+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29186000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,FY,2015-01-01,2015-12-31,2018-04-13 17:50:43+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,3.74
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,FY,2015-01-01,2015-12-31,2018-04-13 17:50:43+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29409000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,FY,2015-01-01,2015-12-31,2018-04-13 17:50:43+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.71
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,FY,2015-01-01,2015-12-31,2018-04-13 17:50:43+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29200000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,FY,2015-01-01,2015-12-31,2018-04-13 17:50:43+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.74
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,570516000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,570516000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,262042000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,262042000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,308515000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,193145000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,55887000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,249032000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,59483000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6034000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,801000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5233000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,54166000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8562000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,45604000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,45604000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,45589000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29186000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.56
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29409000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.54
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29200000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.56
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:25:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,469961000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:25:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,469961000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:25:21+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,206509000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:25:21+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,206509000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:25:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,263452000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:25:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,187445000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:25:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,43336000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:25:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,230781000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:25:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,32671000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:25:21+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5822000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:25:21+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1466000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:25:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7288000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:25:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,25400000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:25:21+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8045000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:25:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,17355000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:25:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,17355000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:25:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,17370000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:25:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29195000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:25:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.59
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:25:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29439000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:25:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.59
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:25:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29400000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3,2015-07-01,2015-09-30,2016-11-02 17:25:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.59
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1448884000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1448884000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,635729000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,635729000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,813155000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,568845000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,137085000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3YTD,2015-01-01,2015-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,705930000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,107225000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,15658000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,50000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3YTD,2015-01-01,2015-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-15608000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,91634000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,28038000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,63596000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3YTD,2015-01-01,2015-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,63596000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3YTD,2015-01-01,2015-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,63611000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3YTD,2015-01-01,2015-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29195000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3YTD,2015-01-01,2015-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.18
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3YTD,2015-01-01,2015-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29439000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3YTD,2015-01-01,2015-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.17
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3YTD,2015-01-01,2015-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29400000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3YTD,2015-01-01,2015-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.18
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2047064000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2047064000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,916543000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,916543000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1130565000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,776382000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,196372000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3TTM,2014-10-01,2015-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,972754000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,157811000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,20658000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,201000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3TTM,2014-10-01,2015-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-20457000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,137423000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,34735000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,102688000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3TTM,2014-10-01,2015-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,102588000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3TTM,2014-10-01,2015-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,102603000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3TTM,2014-10-01,2015-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29195000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3TTM,2014-10-01,2015-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.53
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3TTM,2014-10-01,2015-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29439000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3TTM,2014-10-01,2015-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.51
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3TTM,2014-10-01,2015-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29400000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q3TTM,2014-10-01,2015-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.53
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:20:02+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,506102000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:20:02+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,506102000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:20:02+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,226505000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:20:02+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,226505000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:20:02+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,279597000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:20:02+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,192845000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:20:02+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,46547000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:20:02+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,239392000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:20:02+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,40205000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:20:02+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4834000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:20:02+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4169000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:20:02+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-665000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:20:02+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,39540000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:20:02+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,11117000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:20:02+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,28423000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:20:02+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,28423000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:20:02+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,28423000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:20:02+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29136000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:20:02+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.98
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:20:02+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29381000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:20:02+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.97
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:20:02+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29000000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2,2015-04-01,2015-06-30,2016-08-05 17:20:02+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.98
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,978923000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,978923000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,429220000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,429220000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,549703000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,381400000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,93749000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2YTD,2015-01-01,2015-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,475149000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,74554000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,9836000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1516000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2YTD,2015-01-01,2015-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8320000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,66234000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,19993000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,46241000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2YTD,2015-01-01,2015-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,46241000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2YTD,2015-01-01,2015-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,46241000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2YTD,2015-01-01,2015-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29136000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2YTD,2015-01-01,2015-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.59
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2YTD,2015-01-01,2015-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29381000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2YTD,2015-01-01,2015-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.58
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2YTD,2015-01-01,2015-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29000000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2YTD,2015-01-01,2015-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.59
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2107747000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2107747000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,952102000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,952102000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1155689000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,791487000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,205822000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2TTM,2014-07-01,2015-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,997309000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,158380000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,22546000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1387000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2TTM,2014-07-01,2015-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-23933000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,134499000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,37657000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,96842000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2TTM,2014-07-01,2015-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,96742000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2TTM,2014-07-01,2015-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,96742000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2TTM,2014-07-01,2015-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29136000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2TTM,2014-07-01,2015-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.34
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2TTM,2014-07-01,2015-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29381000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2TTM,2014-07-01,2015-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.31
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2TTM,2014-07-01,2015-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29000000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q2TTM,2014-07-01,2015-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.34
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,472821000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,472821000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,202715000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,202715000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,270106000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,188555000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,47202000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,235757000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,34349000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5002000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2653000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7655000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,26694000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8876000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,17818000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,17818000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,17818000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29092000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.61
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29289000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.61
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29200000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1,2015-01-01,2015-03-31,2016-05-06 16:06:29+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.61
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2138477000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2138477000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,965187000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,965187000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1173334000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,794480000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,214992000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1TTM,2014-04-01,2015-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1009472000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,163862000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,23276000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3118000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1TTM,2014-04-01,2015-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-20158000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,143756000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,43706000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,100050000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1TTM,2014-04-01,2015-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,99950000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1TTM,2014-04-01,2015-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,99950000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1TTM,2014-04-01,2015-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29092000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1TTM,2014-04-01,2015-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.46
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1TTM,2014-04-01,2015-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29289000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1TTM,2014-04-01,2015-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.43
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1TTM,2014-04-01,2015-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29200000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2015.0,Q1TTM,2014-04-01,2015-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.46
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,FY,2016-01-01,2016-12-31,2019-03-29 21:07:23+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2068172000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,FY,2016-01-01,2016-12-31,2019-03-29 21:07:23+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2068172000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,FY,2016-01-01,2016-12-31,2019-03-29 21:07:23+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,929744000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,FY,2016-01-01,2016-12-31,2019-03-29 21:07:23+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,929744000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,FY,2016-01-01,2016-12-31,2019-03-29 21:07:23+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1138428000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,FY,2016-01-01,2016-12-31,2019-03-29 21:07:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,814697000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,FY,2016-01-01,2016-12-31,2019-03-29 21:07:23+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,205708000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,FY,2016-01-01,2016-12-31,2019-03-29 21:07:23+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,62300000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,FY,2016-01-01,2016-12-31,2019-03-29 21:07:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1082705000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,FY,2016-01-01,2016-12-31,2019-03-29 21:07:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,55718000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,FY,2016-01-01,2016-12-31,2019-03-29 21:07:23+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,23380000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,FY,2016-01-01,2016-12-31,2019-03-29 21:07:23+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,9258000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,FY,2016-01-01,2016-12-31,2019-03-29 21:07:23+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-14122000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,FY,2016-01-01,2016-12-31,2019-03-29 21:07:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,41600000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,FY,2016-01-01,2016-12-31,2019-03-29 21:07:23+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,15600000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,FY,2016-01-01,2016-12-31,2019-03-29 21:07:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,26000000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,FY,2016-01-01,2016-12-31,2019-03-29 21:07:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,26000000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,FY,2016-01-01,2016-12-31,2019-03-29 21:07:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,26000000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,FY,2016-01-01,2016-12-31,2019-03-29 21:07:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29440000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,FY,2016-01-01,2016-12-31,2019-03-29 21:07:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.88
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,FY,2016-01-01,2016-12-31,2019-03-29 21:07:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29646000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,FY,2016-01-01,2016-12-31,2019-03-29 21:07:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.88
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,FY,2016-01-01,2016-12-31,2019-03-29 21:07:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29500000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,FY,2016-01-01,2016-12-31,2019-03-29 21:07:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.88
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,571453000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,571453000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,256755000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,256755000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,314698000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,217993000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,57387000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,59940000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,335320000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-20627000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6534000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-966000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-7500000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-28200000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-5452000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22748000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22743000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-22695000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29440000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.78
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29646000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.77
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29500000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.78
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,508745000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,508745000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,229276000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,229276000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,279469000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,201452000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,49924000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,251376000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,28093000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5634000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,190000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5444000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,22700000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,4283000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,18417000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,18417000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,18405000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29444000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.63
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29671000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.62
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29200000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3,2016-07-01,2016-09-30,2017-11-09 16:12:24+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.63
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1496719000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1496719000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,672989000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,672989000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,823730000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,596704000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,148321000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,2360000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3YTD,2016-01-01,2016-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,747385000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,76345000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,16846000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,10224000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3YTD,2016-01-01,2016-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6622000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,69800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,21052000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,48748000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3YTD,2016-01-01,2016-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,48743000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3YTD,2016-01-01,2016-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,48695000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3YTD,2016-01-01,2016-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29444000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3YTD,2016-01-01,2016-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.66
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3YTD,2016-01-01,2016-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29671000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3YTD,2016-01-01,2016-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.65
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3YTD,2016-01-01,2016-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29200000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3YTD,2016-01-01,2016-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.66
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2067235000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2067235000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,935031000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,935031000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1132245000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,789849000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,204208000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,2360000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3TTM,2015-10-01,2016-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,996417000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,135828000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,22880000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,11025000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3TTM,2015-10-01,2016-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-11855000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,123966000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,29614000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,94352000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3TTM,2015-10-01,2016-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,94347000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3TTM,2015-10-01,2016-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,94284000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3TTM,2015-10-01,2016-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29444000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3TTM,2015-10-01,2016-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.22
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3TTM,2015-10-01,2016-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29671000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3TTM,2015-10-01,2016-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.19
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3TTM,2015-10-01,2016-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29200000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q3TTM,2015-10-01,2016-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.22
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,516777000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,516777000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,236545000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,236545000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,280232000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,205536000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,49811000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,2360000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,257707000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,22525000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5632000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,9963000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,4331000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,26900000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8850000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,18050000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,18050000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,18014000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29398000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.61
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29589000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.61
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29500000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2,2016-04-01,2016-06-30,2017-08-07 15:28:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.61
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,987974000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,987974000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,443713000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,443713000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,544261000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,395252000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,98397000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,2360000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2YTD,2016-01-01,2016-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,496009000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,48252000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11212000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,10034000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2YTD,2016-01-01,2016-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1178000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,47100000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,16769000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,30331000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2YTD,2016-01-01,2016-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,30326000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2YTD,2016-01-01,2016-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,30290000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2YTD,2016-01-01,2016-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29398000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2YTD,2016-01-01,2016-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.03
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2YTD,2016-01-01,2016-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29589000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2YTD,2016-01-01,2016-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.03
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2YTD,2016-01-01,2016-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29500000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2YTD,2016-01-01,2016-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.03
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2028451000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2028451000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,912264000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,912264000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1116228000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,775842000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,197620000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,2360000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2TTM,2015-07-01,2016-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,975822000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,140406000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,23068000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,9369000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2TTM,2015-07-01,2016-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-13699000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,126666000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,33376000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,93290000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2TTM,2015-07-01,2016-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,93285000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2TTM,2015-07-01,2016-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,93249000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2TTM,2015-07-01,2016-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29398000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2TTM,2015-07-01,2016-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.18
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2TTM,2015-07-01,2016-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29589000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2TTM,2015-07-01,2016-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.16
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2TTM,2015-07-01,2016-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29500000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q2TTM,2015-07-01,2016-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.18
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,471197000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,471197000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,207168000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,207168000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,264029000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,189716000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,48586000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,238302000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,25727000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5580000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,71000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5509000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,20200000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,7919000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12281000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,12276000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,12276000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29364000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.42
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29506000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.42
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29200000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1,2016-01-01,2016-03-31,2017-05-08 18:17:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.42
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2017776000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2017776000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,902224000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,902224000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1115593000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,763151000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,194356000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1TTM,2015-04-01,2016-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,957507000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,158086000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,22270000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,3575000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1TTM,2015-04-01,2016-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-18695000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,139306000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,35643000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,103663000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1TTM,2015-04-01,2016-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,103658000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1TTM,2015-04-01,2016-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,103658000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1TTM,2015-04-01,2016-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29364000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1TTM,2015-04-01,2016-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,3.55
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1TTM,2015-04-01,2016-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29506000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1TTM,2015-04-01,2016-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,3.52
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1TTM,2015-04-01,2016-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29200000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2016.0,Q1TTM,2015-04-01,2016-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,3.55
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,FY,2017-01-01,2017-12-31,2020-03-02 07:53:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2160153000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,FY,2017-01-01,2017-12-31,2020-03-02 07:53:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2160153000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,FY,2017-01-01,2017-12-31,2020-03-02 07:53:45+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,972450000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,FY,2017-01-01,2017-12-31,2020-03-02 07:53:45+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,972450000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,FY,2017-01-01,2017-12-31,2020-03-02 07:53:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1187703000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,FY,2017-01-01,2017-12-31,2020-03-02 07:53:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,806790000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,FY,2017-01-01,2017-12-31,2020-03-02 07:53:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,250157000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,FY,2017-01-01,2017-12-31,2020-03-02 07:53:45+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,11506000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,FY,2017-01-01,2017-12-31,2020-03-02 07:53:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1068453000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,FY,2017-01-01,2017-12-31,2020-03-02 07:53:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,119250000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,FY,2017-01-01,2017-12-31,2020-03-02 07:53:45+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,23014000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,FY,2017-01-01,2017-12-31,2020-03-02 07:53:45+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1569000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,FY,2017-01-01,2017-12-31,2020-03-02 07:53:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-21445000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,FY,2017-01-01,2017-12-31,2020-03-02 07:53:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,97805000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,FY,2017-01-01,2017-12-31,2020-03-02 07:53:45+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-24444000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,FY,2017-01-01,2017-12-31,2020-03-02 07:53:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,122249000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,FY,2017-01-01,2017-12-31,2020-03-02 07:53:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,122249000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,FY,2017-01-01,2017-12-31,2020-03-02 07:53:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,122249000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,FY,2017-01-01,2017-12-31,2020-03-02 07:53:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29655000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,FY,2017-01-01,2017-12-31,2020-03-02 07:53:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,4.12
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,FY,2017-01-01,2017-12-31,2020-03-02 07:53:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30034000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,FY,2017-01-01,2017-12-31,2020-03-02 07:53:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.07
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,FY,2017-01-01,2017-12-31,2020-03-02 07:53:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29700000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,FY,2017-01-01,2017-12-31,2020-03-02 07:53:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.12
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,621253000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,621253000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,276038000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,276038000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,345257000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,201730000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,76041000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,11506000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,289277000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,55980000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5781000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-4225000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-10006000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,46005000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-36784000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,82789000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,82747000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,82747000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29655000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,2.79
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30034000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,2.76
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29700000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,2.79
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 19:47:07+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,534100000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 19:47:07+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,534100000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 19:47:07+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,235133000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 19:47:07+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,235133000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 19:47:07+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,299008000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 19:47:07+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,198169000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 19:47:07+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,62077000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 19:47:07+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,260246000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 19:47:07+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,38762000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 19:47:07+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5872000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 19:47:07+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-2263000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 19:47:07+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-8135000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 19:47:07+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,30600000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 19:47:07+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,8521000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 19:47:07+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,22079000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 19:47:07+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,22067000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 19:47:07+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,22067000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 19:47:07+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29660000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 19:47:07+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.74
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 19:47:07+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30052000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 19:47:07+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.73
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 19:47:07+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 19:47:07+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.74
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1538900000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1538900000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,696412000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,696412000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,842446000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,605060000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,174116000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3YTD,2017-01-01,2017-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,779176000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,63270000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,17233000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,5794000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3YTD,2017-01-01,2017-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-11439000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,51800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,12340000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,39460000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3YTD,2017-01-01,2017-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,39502000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3YTD,2017-01-01,2017-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,39502000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3YTD,2017-01-01,2017-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29660000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3YTD,2017-01-01,2017-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,1.33
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3YTD,2017-01-01,2017-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30052000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3YTD,2017-01-01,2017-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,1.31
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3YTD,2017-01-01,2017-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3YTD,2017-01-01,2017-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,1.33
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2110353000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2110353000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,953167000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,953167000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1157144000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,823053000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,231503000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,59940000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3TTM,2016-10-01,2017-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1114496000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,42643000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,23767000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,4828000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3TTM,2016-10-01,2017-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-18939000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,23600000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,6888000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,16712000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3TTM,2016-10-01,2017-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,16759000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3TTM,2016-10-01,2017-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,16807000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3TTM,2016-10-01,2017-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29660000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3TTM,2016-10-01,2017-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.55
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3TTM,2016-10-01,2017-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30052000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3TTM,2016-10-01,2017-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.54
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3TTM,2016-10-01,2017-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q3TTM,2016-10-01,2017-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.55
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 13:48:41+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,504700000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 13:48:41+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,504700000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 13:48:41+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,231291000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 13:48:41+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,231291000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 13:48:41+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,273375000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 13:48:41+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,212489000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 13:48:41+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,62587000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 13:48:41+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,275076000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 13:48:41+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1701000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 13:48:41+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6045000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 13:48:41+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,8846000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 13:48:41+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2801000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 13:48:41+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1100000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 13:48:41+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-3915000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 13:48:41+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,5015000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 13:48:41+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,5035000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 13:48:41+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,5035000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 13:48:41+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29613000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 13:48:41+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.17
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 13:48:41+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30006000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 13:48:41+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.17
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 13:48:41+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29600000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 13:48:41+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.17
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1004800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1004800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,461279000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,461279000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,543438000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,406891000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,112039000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2YTD,2017-01-01,2017-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,518930000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,24508000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11361000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,8057000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2YTD,2017-01-01,2017-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3304000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,21200000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,3819000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,17381000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2YTD,2017-01-01,2017-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,17435000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2YTD,2017-01-01,2017-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,17435000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2YTD,2017-01-01,2017-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29613000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2YTD,2017-01-01,2017-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.59
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2YTD,2017-01-01,2017-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30006000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2YTD,2017-01-01,2017-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.58
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2YTD,2017-01-01,2017-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29600000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2YTD,2017-01-01,2017-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.59
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2084998000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2084998000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,947310000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,947310000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1137605000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,826336000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,219350000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,59940000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2TTM,2016-07-01,2017-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1105626000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,31974000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,23529000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,7281000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2TTM,2016-07-01,2017-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-16248000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,15700000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,2650000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,13050000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2TTM,2016-07-01,2017-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,13109000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2TTM,2016-07-01,2017-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,13145000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2TTM,2016-07-01,2017-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29613000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2TTM,2016-07-01,2017-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.44
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2TTM,2016-07-01,2017-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30006000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2TTM,2016-07-01,2017-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.43
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2TTM,2016-07-01,2017-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29600000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q2TTM,2016-07-01,2017-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.44
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,500100000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,500100000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,229988000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,229988000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,270063000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,194402000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,49452000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,243854000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,26209000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5316000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-789000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6105000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,20100000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,7734000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,12366000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,12400000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,12400000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29580000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.42
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29911000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.41
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29500000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1,2017-01-01,2017-03-31,2018-05-10 17:00:09+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.42
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2097075000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2097075000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,952564000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,952564000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1144462000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,819383000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,206574000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,62300000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1TTM,2016-04-01,2017-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1088257000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,56200000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,23116000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,8398000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1TTM,2016-04-01,2017-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-14718000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,41500000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,15415000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,26085000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1TTM,2016-04-01,2017-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,26124000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1TTM,2016-04-01,2017-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,26124000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1TTM,2016-04-01,2017-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29580000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1TTM,2016-04-01,2017-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.88
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1TTM,2016-04-01,2017-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29911000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1TTM,2016-04-01,2017-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.87
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1TTM,2016-04-01,2017-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29500000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2017.0,Q1TTM,2016-04-01,2017-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.88
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,FY,2018-01-01,2018-12-31,2020-03-02 07:53:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2289415000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,FY,2018-01-01,2018-12-31,2020-03-02 07:53:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2289415000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,FY,2018-01-01,2018-12-31,2020-03-02 07:53:45+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1066264000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,FY,2018-01-01,2018-12-31,2020-03-02 07:53:45+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1066264000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,FY,2018-01-01,2018-12-31,2020-03-02 07:53:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1223151000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,FY,2018-01-01,2018-12-31,2020-03-02 07:53:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,834783000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,FY,2018-01-01,2018-12-31,2020-03-02 07:53:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,199196000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,FY,2018-01-01,2018-12-31,2020-03-02 07:53:45+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,292513000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,FY,2018-01-01,2018-12-31,2020-03-02 07:53:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1326492000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,FY,2018-01-01,2018-12-31,2020-03-02 07:53:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-103341000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,FY,2018-01-01,2018-12-31,2020-03-02 07:53:45+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,23962000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,FY,2018-01-01,2018-12-31,2020-03-02 07:53:45+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,639962000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,FY,2018-01-01,2018-12-31,2020-03-02 07:53:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,616000000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,FY,2018-01-01,2018-12-31,2020-03-02 07:53:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,512659000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,FY,2018-01-01,2018-12-31,2020-03-02 07:53:45+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,147045000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,FY,2018-01-01,2018-12-31,2020-03-02 07:53:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,365614000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,FY,2018-01-01,2018-12-31,2020-03-02 07:53:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,365614000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,FY,2018-01-01,2018-12-31,2020-03-02 07:53:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,365614000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,FY,2018-01-01,2018-12-31,2020-03-02 07:53:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29836000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,FY,2018-01-01,2018-12-31,2020-03-02 07:53:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,12.25
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,FY,2018-01-01,2018-12-31,2020-03-02 07:53:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30228000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,FY,2018-01-01,2018-12-31,2020-03-02 07:53:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,12.1
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,FY,2018-01-01,2018-12-31,2020-03-02 07:53:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,FY,2018-01-01,2018-12-31,2020-03-02 07:53:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,12.25
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,616847000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,616847000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,284282000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,284282000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,332565000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,214032000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,53074000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,292513000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,559619000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-227054000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6139000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-808054000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-814193000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1041247000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-212718000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-828529000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-828529000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-828529000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29836000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-27.81
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30228000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-27.43
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-27.81
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:01:23+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,545138000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:01:23+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,545138000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:01:23+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,258422000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:01:23+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,258422000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:01:23+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,286716000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:01:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,201196000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:01:23+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,49245000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:01:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,250441000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:01:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,36275000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:01:23+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6064000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:01:23+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,319920000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:01:23+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,313856000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:01:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,350131000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:01:23+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,80805000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:01:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,269326000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:01:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,269326000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:01:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,269326000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:01:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29863000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:01:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,9.02
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:01:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30292000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:01:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,8.89
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:01:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29900000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3,2018-07-01,2018-09-30,2019-11-01 17:01:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,9.02
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1672568000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1672568000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,781982000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,781982000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,890586000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,620751000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,146122000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3YTD,2018-01-01,2018-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,766873000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,123713000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,17823000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1448016000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3YTD,2018-01-01,2018-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1430193000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1553906000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,359763000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1194143000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3YTD,2018-01-01,2018-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1194143000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3YTD,2018-01-01,2018-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1194143000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3YTD,2018-01-01,2018-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29863000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3YTD,2018-01-01,2018-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,40.06
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3YTD,2018-01-01,2018-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30292000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3YTD,2018-01-01,2018-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,39.53
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3YTD,2018-01-01,2018-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29900000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3YTD,2018-01-01,2018-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,40.06
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2293821000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2293821000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1058020000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1058020000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1235843000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,822481000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,222163000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,11506000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3TTM,2017-10-01,2018-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1056150000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,179693000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,23604000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1443791000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3TTM,2017-10-01,2018-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1420187000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1599911000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,322979000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1276932000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3TTM,2017-10-01,2018-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1276890000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3TTM,2017-10-01,2018-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1276890000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3TTM,2017-10-01,2018-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29863000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3TTM,2017-10-01,2018-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,42.85
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3TTM,2017-10-01,2018-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30292000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3TTM,2017-10-01,2018-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,42.29
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3TTM,2017-10-01,2018-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29900000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q3TTM,2017-10-01,2018-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,42.85
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 14:03:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,575911000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 14:03:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,575911000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 14:03:10+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,274244000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 14:03:10+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,274244000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 14:03:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,301667000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 14:03:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,210425000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 14:03:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,47450000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 14:03:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,257875000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 14:03:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,43792000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 14:03:10+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5977000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 14:03:10+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,302271000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 14:03:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,296294000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 14:03:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,340086000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 14:03:10+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,72043000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 14:03:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,268043000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 14:03:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,268043000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 14:03:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,268043000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 14:03:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29814000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 14:03:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,8.99
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 14:03:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30219000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 14:03:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,8.87
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 14:03:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2,2018-04-01,2018-06-30,2019-08-06 14:03:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,8.99
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1127430000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1127430000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,523560000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,523560000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,603870000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,419555000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,96877000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2YTD,2018-01-01,2018-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,516432000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,87438000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11759000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1128096000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2YTD,2018-01-01,2018-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1116337000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1203775000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,278958000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,924817000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2YTD,2018-01-01,2018-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,924817000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2YTD,2018-01-01,2018-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,924817000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2YTD,2018-01-01,2018-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29814000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2YTD,2018-01-01,2018-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,31.04
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2YTD,2018-01-01,2018-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30219000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2YTD,2018-01-01,2018-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,30.64
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2YTD,2018-01-01,2018-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2YTD,2018-01-01,2018-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,31.04
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2282783000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2282783000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1034731000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1034731000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1248135000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,819454000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,234995000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,11506000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2TTM,2017-07-01,2018-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1065955000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,182180000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,23412000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1121608000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2TTM,2017-07-01,2018-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1098196000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1280380000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,250695000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1029685000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2TTM,2017-07-01,2018-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1029631000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2TTM,2017-07-01,2018-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1029631000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2TTM,2017-07-01,2018-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29814000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2TTM,2017-07-01,2018-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,34.57
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2TTM,2017-07-01,2018-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30219000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2TTM,2017-07-01,2018-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,34.13
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2TTM,2017-07-01,2018-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q2TTM,2017-07-01,2018-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,34.57
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,551519000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,551519000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,249316000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,249316000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,302203000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,209130000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,49427000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,258557000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,43646000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5782000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,825825000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,820043000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,863689000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,206915000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,656774000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,656774000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,656774000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29787000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,22.05
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30171000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,21.77
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1,2018-01-01,2018-03-31,2019-05-10 16:08:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,22.05
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2211572000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2211572000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,991778000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,991778000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1219843000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,821518000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,250132000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,11506000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1TTM,2017-04-01,2018-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1083156000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,136687000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,23480000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,828183000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1TTM,2017-04-01,2018-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,804703000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,941394000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,174737000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,766657000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1TTM,2017-04-01,2018-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,766623000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1TTM,2017-04-01,2018-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,766623000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1TTM,2017-04-01,2018-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29787000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1TTM,2017-04-01,2018-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,25.75
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1TTM,2017-04-01,2018-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30171000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1TTM,2017-04-01,2018-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,25.43
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1TTM,2017-04-01,2018-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2018.0,Q1TTM,2017-04-01,2018-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,25.75
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,624407000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,624407000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,293989000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,293989000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,330439000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,214165000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,57069000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,271234000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,59205000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6064000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,646289000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,640225000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,699430000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,145944000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,553486000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,553486000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,553486000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29843000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,18.5
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30184000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,18.35
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,18.5
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,FY,2019-01-01,2019-12-31,2020-03-02 07:53:45+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2311659000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,FY,2019-01-01,2019-12-31,2020-03-02 07:53:45+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2311659000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,FY,2019-01-01,2019-12-31,2020-03-02 07:53:45+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1054663000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,FY,2019-01-01,2019-12-31,2020-03-02 07:53:45+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1054663000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,FY,2019-01-01,2019-12-31,2020-03-02 07:53:45+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1256996000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,FY,2019-01-01,2019-12-31,2020-03-02 07:53:45+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,824625000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,FY,2019-01-01,2019-12-31,2020-03-02 07:53:45+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,202710000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,FY,2019-01-01,2019-12-31,2020-03-02 07:53:45+00:00,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,0.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,FY,2019-01-01,2019-12-31,2020-03-02 07:53:45+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1027335000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,FY,2019-01-01,2019-12-31,2020-03-02 07:53:45+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,229661000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,FY,2019-01-01,2019-12-31,2020-03-02 07:53:45+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,23416000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,FY,2019-01-01,2019-12-31,2020-03-02 07:53:45+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,2054836000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,FY,2019-01-01,2019-12-31,2020-03-02 07:53:45+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,2031420000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,FY,2019-01-01,2019-12-31,2020-03-02 07:53:45+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2261081000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,FY,2019-01-01,2019-12-31,2020-03-02 07:53:45+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,502406000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,FY,2019-01-01,2019-12-31,2020-03-02 07:53:45+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1758675000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,FY,2019-01-01,2019-12-31,2020-03-02 07:53:45+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1758675000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,FY,2019-01-01,2019-12-31,2020-03-02 07:53:45+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1758675000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,FY,2019-01-01,2019-12-31,2020-03-02 07:53:45+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29843000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,FY,2019-01-01,2019-12-31,2020-03-02 07:53:45+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,58.93
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,FY,2019-01-01,2019-12-31,2020-03-02 07:53:45+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30184000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,FY,2019-01-01,2019-12-31,2020-03-02 07:53:45+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,58.27
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,FY,2019-01-01,2019-12-31,2020-03-02 07:53:45+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,FY,2019-01-01,2019-12-31,2020-03-02 07:53:45+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,58.93
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:01:23+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,560633000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:01:23+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,560633000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:01:23+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,253607000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:01:23+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,253607000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:01:23+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,307026000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:01:23+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,201622000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:01:23+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,47944000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:01:23+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,249566000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:01:23+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,57460000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:01:23+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5525000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:01:23+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-387151000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:01:23+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-392676000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:01:23+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-335216000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:01:23+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,-76400000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:01:23+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-258816000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:01:23+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-258816000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:01:23+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-258816000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:01:23+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29831000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:01:23+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-8.68
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:01:23+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29831000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:01:23+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-8.68
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:01:23+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3,2019-07-01,2019-09-30,2019-11-01 17:01:23+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-8.68
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1687252000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1687252000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,760674000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,760674000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,926557000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,610460000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,145641000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3YTD,2019-01-01,2019-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,756101000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,170456000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,17352000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1408547000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3YTD,2019-01-01,2019-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1391195000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1561651000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,356462000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1205189000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3YTD,2019-01-01,2019-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1205189000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3YTD,2019-01-01,2019-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1205189000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3YTD,2019-01-01,2019-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29831000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3YTD,2019-01-01,2019-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,40.43
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3YTD,2019-01-01,2019-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29831000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3YTD,2019-01-01,2019-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,39.92
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3YTD,2019-01-01,2019-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3YTD,2019-01-01,2019-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,40.43
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2304099000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2304099000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1044956000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1044956000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1259122000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,824492000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,198715000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,292513000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3TTM,2018-10-01,2019-09-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1315720000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-56598000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,23491000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,600493000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3TTM,2018-10-01,2019-09-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,577002000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,520404000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,143744000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,376660000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3TTM,2018-10-01,2019-09-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,376660000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3TTM,2018-10-01,2019-09-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,376660000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3TTM,2018-10-01,2019-09-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29831000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3TTM,2018-10-01,2019-09-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,12.62
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3TTM,2018-10-01,2019-09-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,29831000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3TTM,2018-10-01,2019-09-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,12.49
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3TTM,2018-10-01,2019-09-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q3TTM,2018-10-01,2019-09-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,12.62
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 14:03:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,572619000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 14:03:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,572619000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 14:03:10+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,264850000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 14:03:10+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,264850000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 14:03:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,307769000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 14:03:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,201257000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 14:03:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,50122000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 14:03:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,251379000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 14:03:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,56390000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 14:03:10+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5841000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 14:03:10+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,719052000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 14:03:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,713211000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 14:03:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,769601000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 14:03:10+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,170791000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 14:03:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,598810000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 14:03:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,598810000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 14:03:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,598810000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 14:03:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29814000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 14:03:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,20.08
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 14:03:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30154000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 14:03:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,19.86
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 14:03:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2,2019-04-01,2019-06-30,2019-08-06 14:03:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,20.08
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1126619000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1126619000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,507067000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,507067000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,619531000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,408838000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,97697000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2YTD,2019-01-01,2019-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,506535000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,112996000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11827000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1795698000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2YTD,2019-01-01,2019-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1783871000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1896867000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,432862000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1464005000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2YTD,2019-01-01,2019-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1464005000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2YTD,2019-01-01,2019-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1464005000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2YTD,2019-01-01,2019-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29814000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2YTD,2019-01-01,2019-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,49.11
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2YTD,2019-01-01,2019-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30154000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2YTD,2019-01-01,2019-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,48.6
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2YTD,2019-01-01,2019-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2YTD,2019-01-01,2019-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,49.11
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2288604000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2288604000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1049771000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1049771000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1238812000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,824066000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,200016000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,292513000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2TTM,2018-07-01,2019-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1316595000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-77783000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,24030000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1307564000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2TTM,2018-07-01,2019-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1283534000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1205751000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,300949000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,904802000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2TTM,2018-07-01,2019-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,904802000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2TTM,2018-07-01,2019-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,904802000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2TTM,2018-07-01,2019-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29814000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2TTM,2018-07-01,2019-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,30.32
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2TTM,2018-07-01,2019-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30154000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2TTM,2018-07-01,2019-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,30.06
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2TTM,2018-07-01,2019-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q2TTM,2018-07-01,2019-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,30.32
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,554000000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,554000000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,242217000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,242217000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,311762000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,207581000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,47575000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,255156000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,56606000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5986000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1076646000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1070660000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,1127266000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,262071000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,865195000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,865195000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,865195000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29801000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,29.03
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30104000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,28.74
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1,2019-01-01,2019-03-31,2020-05-07 21:55:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,29.03
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2291896000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2291896000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1059165000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1059165000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1232710000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,833234000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,197344000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingexpenses,impairmentexpense,Impairment Charge,+,debit,usd,292513000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1TTM,2018-04-01,2019-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1323091000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-90381000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,24166000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,890783000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1TTM,2018-04-01,2019-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,866617000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,776236000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,202201000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,574035000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1TTM,2018-04-01,2019-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,574035000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1TTM,2018-04-01,2019-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,574035000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1TTM,2018-04-01,2019-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29801000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1TTM,2018-04-01,2019-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,19.23
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1TTM,2018-04-01,2019-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30104000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1TTM,2018-04-01,2019-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,19.07
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1TTM,2018-04-01,2019-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29800000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2019.0,Q1TTM,2018-04-01,2019-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,19.23
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2329259000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2329259000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,1066722000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,1066722000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1262602000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,810736000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,204438000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1TTM,2019-04-01,2020-03-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,1015174000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,247428000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,23120000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1808206000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1TTM,2019-04-01,2020-03-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1785086000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,2032514000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,453122000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,1579392000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1TTM,2019-04-01,2020-03-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,1579392000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1TTM,2019-04-01,2020-03-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,1579392000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1TTM,2019-04-01,2020-03-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29865000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1TTM,2019-04-01,2020-03-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,52.87
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1TTM,2019-04-01,2020-03-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30196000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1TTM,2019-04-01,2020-03-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,52.25
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1TTM,2019-04-01,2020-03-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29900000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1TTM,2019-04-01,2020-03-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,52.87
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:55:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,571600000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:55:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,571600000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:55:32+00:00,totalcostofrevenue,operatingcostofrevenue,Operating Cost of Revenue,+,debit,usd,254276000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:55:32+00:00,totalgrossprofit,totalcostofrevenue,Total Cost of Revenue,-,debit,usd,254276000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:55:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,317368000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:55:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,193692000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:55:32+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,49303000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:55:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,242995000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:55:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,74373000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:55:32+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5690000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:55:32+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,830016000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:55:32+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,824326000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:55:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,898699000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:55:32+00:00,netincomecontinuing,incometaxexpense,Income Tax Expense,-,debit,usd,212787000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:55:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,685912000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:55:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,685912000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:55:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,685912000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:55:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,29865000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:55:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,22.97
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:55:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,30196000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:55:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,22.72
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:55:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,29900000.0
Bio Rad Laboratories Inc,BIO,549300ZC1GPV35XYDK53,0000012208,2020.0,Q1,2020-01-01,2020-03-31,2020-05-07 21:55:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,22.97
